Plasma antioxidant status and motor features in de novo Chinese Parkinson's disease patients

References

• Dervan AG, Meshul CK, Beales M, et al. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Exp Neurol 2004;190:145–56.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Mcdermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529–34.
   PubMed Web of Science ®Google Scholar
• Rajput AH, Voll A, Rajput ML, et al. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 2009;73:206–12.
   PubMed Web of Science ®Google Scholar
• Linazasoro G. Classical Parkinson disease versus Parkinson complex–reflections against staging and in favour of heterogeneity. Eur J Neurol 2007;14:721–8.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611–5.
   PubMedGoogle Scholar
• Hauser DN, Hastings TG. Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism. Neurobiol Dis 2013;51:35–42.
   PubMed Web of Science ®Google Scholar
• Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson's disease. J Parkinsons Dis 2013;3:461–91.
   PubMedGoogle Scholar
• Chen CM, Liu JL, Wu YR, et al. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Neurobiol Dis 2009;33:429–35.
   PubMed Web of Science ®Google Scholar
• Nikam S, Nikam P, Ahaley SK, et al. Oxidative stress in Parkinson's disease. Indian J Clin Biochem 2009;24:98–101.
   PubMedGoogle Scholar
• Gruden MA, Yanamandra K, Kucheryanu VG, et al. Correlation between protective immunity to alpha-synuclein aggregates, oxidative stress and inflammation. Neuroimmunomodulation 2012;19:334–42.
   PubMed Web of Science ®Google Scholar
• Kumudini N, Uma A, Devi YP, et al. Association of Parkinson's disease with altered serum levels of lead and transition metals among South Indian subjects. Indian J Biochem Biophys 2014;51:121–6.
   PubMed Web of Science ®Google Scholar
• Bogdanov M, Matson WR, Wang L, et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 2008;131:389–96.
   PubMed Web of Science ®Google Scholar
• Baillet A, Chanteperdrix V, Trocme C, et al. The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochem Res 2010;35:1530–7.
   PubMed Web of Science ®Google Scholar
• Chalimoniuk M, Stepien A, Strosznajder JB. Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson disease. Clin Neuropharmacol 2004;27:223–9.
   PubMed Web of Science ®Google Scholar
• Elokda A, Difrancisco-Donoghue J, Lamberg EM, et al. Effects of exercise induced oxidative stress on glutathione levels in Parkinson's disease on and off medication. J Neurol 2010;257:1648–53.
   PubMed Web of Science ®Google Scholar
• Gatto EM, Carreras MC, Pargament GA, et al. Neutrophil function, nitric oxide, and blood oxidative stress in Parkinson's disease. Mov Disord 1996;11:261–7.
   PubMed Web of Science ®Google Scholar
• Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–4.
   PubMed Web of Science ®Google Scholar
• Fahn S, Elton R. Members of the UPDRS development committee unified parkinson's disease rating scale. In Fahn S, Marsden CD, Calne DB, Lieberman A, eds. Recent developments in Parkinson's disease. Unified Parkinson's Disease rating Scale. Florham Park, NJ: McMillan Health Care Information; 1987:153–63.
   Google Scholar
• Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, Mchugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.
   PubMed Web of Science ®Google Scholar
• Barthwal MK, Srivastava N, Shukla R, et al. Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients. Acta Neurol Scand 1999;100:300–4.
   PubMed Web of Science ®Google Scholar
• Ciriolo MR, Fiskin K, De Martino A, et al. Age-related changes in Cu,Zn superoxide dismutase, Se-dependent and -independent glutathione peroxidase and catalase activities in specific areas of rat brain. Mech Ageing Dev 1991;61:287–97.
   PubMed Web of Science ®Google Scholar
• Tsay HJ, Wang P, Wang SL, et al. Age-associated changes of superoxide dismutase and catalase activities in the rat brain. J Biomed Sci, 2000;7:466–74.
   PubMed Web of Science ®Google Scholar
• Sharma A, Kaur P, Kumar B, et al. Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population. Parkinsonism Relat Disord 2008;14:52–7.
   PubMed Web of Science ®Google Scholar
• Wali MA, Suleiman SA, Kadoumi OF, et al. Superoxide radical concentration and superoxide dismutase (SOD) enzyme activity in varicose veins. Ann Thorac Cardiovasc Surg 2002;8:286–90.
   PubMedGoogle Scholar
• Lin CC, Huang HH, Hu CW, et al. Trace elements, oxidative stress and glycemic control in young people with type 1 diabetes mellitus. J Trace Elem Med Biol 2014;28:18–22.
   PubMed Web of Science ®Google Scholar
• Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011;283:65–87.
   PubMed Web of Science ®Google Scholar
• Bolzan AD, Bianchi MS, Bianchi NO. Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking. Clin Biochem 1997;30:449–54.
   PubMed Web of Science ®Google Scholar
• Karabulut AB, Kafkas ME, Kafkas AS, et al. The effect of regular exercise and massage on oxidant and antioxidant parameters. Indian J Physiol Pharmacol 2013;57:378–83.
   PubMedGoogle Scholar
• Rowinski R, Kozakiewicz M, Kedziora-Kornatowska K, et al. Markers of oxidative stress and erythrocyte antioxidant enzyme activity in older men and women with differing physical activity. Exp Gerontol 2013;48:1141–6.
   PubMed Web of Science ®Google Scholar
• Awobajo FO, Olawale OA, Bassey S. Changes in blood glucose, lipid profile and antioxidant activities in trained and untrained adult male subjects during programmed exercise on the treadmill. Nig Q J Hosp Med 2013;23:117–24.
   PubMedGoogle Scholar
• Zhao HW, Lin J, Wang XB, et al. Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson's disease. PLOS One 2013;8:e83060.
   PubMed Web of Science ®Google Scholar
• Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med 2013;62:13–25.
   PubMed Web of Science ®Google Scholar
• Gironi M, Bianchi A, Russo A, et al. Oxidative imbalance in different neurodegenerative diseases with memory impairment. Neurodegener Dis 2011;8:129–37.
   PubMed Web of Science ®Google Scholar
• Sudha K, Rao AV, Rao S, et al. Free radical toxicity and antioxidants in Parkinson's disease. Neurol India 2003;51:60–2.
   PubMed Web of Science ®Google Scholar
• Kalra J, Rajput AH, Mantha SV, et al. Serum antioxidant enzyme activity in Parkinson's disease. Mol Cell Biochem 1992;110:165–8.
   PubMed Web of Science ®Google Scholar
• Serra JA, Dominguez RO, De Lustig ES, et al. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients. J Neural Transm 2001;108:1135–48.
   PubMed Web of Science ®Google Scholar
• Kocaturk PA, Akbostanci MC, Tan F, et al. Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease. Pathophysiology 2000;7:63–7.
   PubMedGoogle Scholar
• Martignoni E, Blandini F, Godi L, et al. Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA. Free Radic Biol Med 1999;27:428–37.
   PubMed Web of Science ®Google Scholar
• Watfa G, Dragonas C, Brosche T, et al. Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease. J Nutr Health Aging 2011;15:277–81.
   PubMed Web of Science ®Google Scholar
• Muller T, Kuhn W. Cysteine elevation in levodopa-treated patients with Parkinson's disease. Mov Disord 2009;24:929–32.
   PubMed Web of Science ®Google Scholar